Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of Cabozantinib Dose Reductions for Toxicity With Clinical Effectiveness in Metastatic Renal Cell Carcinoma (mRCC): Results From the Canadian Kidney Cancer Information System (CKCis).
Graham J, Ghosh S, Breau RH, Wood L, Tanguay S, Bosse D, Lalani AK, Bhindi B, Heng D, Finelli A, Fallah-Rad N, Castonguay V, Basappa NS, Soulières D, Pouliot F, Kollmannsberger C, Bjarnason GA. Graham J, et al. Among authors: fallah rad n. Clin Genitourin Cancer. 2024 Jun;22(3):102060. doi: 10.1016/j.clgc.2024.02.011. Epub 2024 Feb 23. Clin Genitourin Cancer. 2024. PMID: 38521648
Genomic characterization of non-schistosomiasis-related squamous cell carcinoma of the urinary bladder: A retrospective exploratory study.
Al-Ezzi EM, Veitch ZW, Salah SH, Van der Kwast TH, Stockley TL, Selvarajah S, Zhang T, Sridhar SS, Sacher AG, Fallah-Rad N, Kulkarni GS, Zlotta AR, Finelli A, Hansen AR. Al-Ezzi EM, et al. PLoS One. 2021 Dec 1;16(12):e0259272. doi: 10.1371/journal.pone.0259272. eCollection 2021. PLoS One. 2021. PMID: 34851968 Free PMC article.
Comprehensive genomic profiling of treatment resistant metastatic castrate sensitive prostate cancer reveals high frequency of potential therapeutic targets.
Kappel C, Jiang DM, Wong B, Zhang T, Selvarajah S, Warner E, Hansen AR, Fallah-Rad N, Sacher AG, Stockley TL, Bedard PL, Sridhar SS. Kappel C, et al. Clin Genitourin Cancer. 2022 Jun;20(3):278-284. doi: 10.1016/j.clgc.2022.02.004. Epub 2022 Feb 22. Clin Genitourin Cancer. 2022. PMID: 35337750 Clinical Trial.
2022 American Society of Clinical Oncology (ASCO): Meeting highlights.
Black PC, Fallah-Rad N, Loblaw A, Kassouf E, Keyes M, Basappa NS, Swaminath A. Black PC, et al. Among authors: fallah rad n. Can Urol Assoc J. 2022 Sep;16(9):E499-E504. doi: 10.5489/cuaj.8097. Can Urol Assoc J. 2022. PMID: 36122414 Free PMC article. No abstract available.
The role of cytoreductive nephrectomy and systemic therapy in the management of tumour thrombus in patients with metastatic renal cell carcinoma.
Mittal A, Al-Ezzi E, Li X, Moloney B, Wilson B, Spiliopoulou P, Sridhar S, Fallah-Rad N, Chung P, Hamilton RJ, O'malley M, Hansen AR. Mittal A, et al. Among authors: fallah rad n. Br J Cancer. 2023 May;128(10):1888-1896. doi: 10.1038/s41416-023-02166-5. Epub 2023 Mar 1. Br J Cancer. 2023. PMID: 36859686 Free PMC article.
Clinicopathologic factors that influence prognosis and survival outcomes in men with metastatic castration-resistant prostate cancer treated with Radium-223.
Al-Ezzi EM, Alqaisi HA, Iafolla MAJ, Wang L, Sridhar SS, Sacher AG, Fallah-Rad N, Jiang DM, Watson GA, Catton CN, Warde PR, Hamilton RJ, Fleshner NE, Zlotta AR, Hansen AR. Al-Ezzi EM, et al. Cancer Med. 2021 Sep;10(17):5775-5782. doi: 10.1002/cam4.4125. Epub 2021 Jul 13. Cancer Med. 2021. PMID: 34254464 Free PMC article.
The Survival Outcomes of the Metastatic Nonclear Cell Renal Cell Carcinoma in the Immunotherapy Era: Princess Margaret Cancer Centre Experience.
Al-Ezzi E, Mittal A, Veitch ZW, Zahralliyali A, Mejia NMD, Abdeljalil O, Alqaisi H, Kumar V, Hansen AR, Fallah-Rad N, Sridhar SS. Al-Ezzi E, et al. Among authors: fallah rad n. J Kidney Cancer VHL. 2024 Mar 2;11(1):41-48. doi: 10.15586/jkcvhl.v11i1.307. eCollection 2024. J Kidney Cancer VHL. 2024. PMID: 38450000 Free PMC article.
Clinical variables associated with immune checkpoint inhibitor outcomes in patients with metastatic urothelial carcinoma: a multicentre retrospective cohort study.
Labidi S, Meti N, Barua R, Li M, Riromar J, Jiang DM, Fallah-Rad N, Sridhar SS, Del Rincon SV, Pezo RC, Ferrario C, Cheng S, Sacher AG, Rose AAN. Labidi S, et al. Among authors: fallah rad n. BMJ Open. 2024 Mar 29;14(3):e081480. doi: 10.1136/bmjopen-2023-081480. BMJ Open. 2024. PMID: 38553056 Free PMC article.
23 results